Diazabenzo[de]anthracen-3-one compounds and methods for...

Details Diazabenzo[de]anthracen-3-one compounds and methods for... Diazabenzo[de]anthracen-3-one compounds and methods for...

2006-01-19

2010-10-26

Habte, Kahsay T (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C544S235000, C544S248000

Reexamination Certificate

active

07820668

ABSTRACT:
The present invention relates to diazabenzo[de]anthracen-3-one compounds which inhibit poly(ADP-ribose) polymerase (“PARP”), compositions containing these compounds and methods for using these PARP inhibitors to treat, prevent and/or ameliorate the effects of the conditions described herein.

REFERENCES:
patent: 6291425 (2001-09-01), Li et al.
patent: 6348475 (2002-02-01), Zhang et al.
patent: 6716828 (2004-04-01), Li et al.
patent: 7307080 (2007-12-01), Li et al.
patent: 7456178 (2008-11-01), Kalish et al.
patent: 7601719 (2009-10-01), Kalish et al.
patent: WO-01/16137 (2001-03-01), None
patent: WO-2004/105700 (2004-12-01), None
patent: WO 2004105700 (2004-12-01), None
Gagne et al. Current Opinion in Cell Biology 2006, 18:145-151.
Chalmers (TiPS vol. 17, pp. 166-172 Apr. 1996.
West, Anthony R., Solid State Chemistry and its Applications, Wiley, New York, 1988, pp. 358 & 365.
Vippagunta et al, “Crystalline Solids” Advanced Drug Delivery Reviews, vol. 48, pp. 3-26 (2001).
Gavezzotti, “Are Crystal Structures Predictable?” Accounts of Chemical Research, vol. 27, pp. 309-314 (1994).
Gagne et al., Corticotrophin-releasing factor receptors: from molecular biology to drug design; Chalmers, TIPS, vol. 17, 166-172 (Apr. 1996).
Combs et al., The expanding role of poly(ADP-ribos) metabolism: current challenges and new persepective; Current Opinion in Cell Biology, 18, 145-151 (2006).
E.S. Newlands et al., 2,6-Dihydroxy-4H-pyridazino[3,4,5-de]quinazoline: A New Ring System; Journal of Heterocyclic Chemistry, vol. 26, 1885-1886 (1989).
“Temozolomide: A Review of its Discovery, Chemical Properties, Pre-clinical Development and Clinical Trails” Cancer Treatment Review, 23, 35-61 (1997).

Affiliated with

Also associated with

Rating

Diazabenzo[de]anthracen-3-one compounds and methods for... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Diazabenzo[de]anthracen-3-one compounds and methods for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Diazabenzo[de]anthracen-3-one compounds and methods for... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4183100